The forecast for antidepressant medicine sales in Sweden from 2024 to 2028 shows a gradual decline when expressed in US Dollars PPP Per Capita. The value for 2024 is 7.9, which decreases slightly to 7.8 in 2025, 7.6 in 2026, 7.5 in 2027, and 7.3 by 2028.
The year-on-year variation percentages indicate a consistent downward trend:
- From 2024 to 2025: -1.27%
- From 2025 to 2026: -2.56%
- From 2026 to 2027: -1.32%
- From 2027 to 2028: -2.67%
The Compound Annual Growth Rate (CAGR) for the period from 2023 to 2028 reflects an average annual decrease of approximately 1.93%.
Future trends to watch for include potential changes in public health policy, the introduction of new therapies, shifts in societal attitudes towards mental health, and economic factors that could influence market dynamics. Continued innovation in the pharmaceutical industry and the evolving digital health landscape may also impact future sales.
